**11. Conclusion**

**Figure 8.** EXCEL study protocol comparing Xience stent with CABG

362 Artery Bypass

**Figure 9.** Absorb Stent- Bioabsorbale everolimus eluted stent

Stents composed of bioabsorbable/biodegradable materials represent an attractive alternative revascularization modality; the justification stems from the short-term need for vessel scaffold‐ ing and avoidance of the potential long-term complications of metallic stents. Compared with Each strategy can have great outcomes in appropriately selected patients. Hard clinical outcomes (death/MI/CVA) are generally similar, need to weigh the risk of potential repetition of procedures with PCI using DES vs. the greater morbidity of CABG. The 3VD and LMCA Disease are high-risk coronary lesions and the least stable subtypes of "stable CAD" PCI and CABG have very similar rates of hard clinical endpoints. Greater rates of recurrent revascu‐ larization with PCI, especially in complex disease, Patient selection and patient preference will generally dictate the best and most appropriate care. The so-called SYNTAX score, evolved for the trial, offers a grading system, based on patient anatomy, to help surgeons and inter‐ ventionalists make this decision. As PCI and CABG are refined further, surgeons and cardi‐ ologists will no doubt learn to use these improved interventional techniques and surgical procedures in a way that will optimize the treatment of each individual patient.
